Results 181 to 190 of about 130,982 (298)

Identifying TNFSF4<sup>low</sup>-MSCs superiorly treating idiopathic pulmonary fibrosis through Tregs differentiation modulation. [PDF]

open access: yesStem Cell Res Ther
Xie Y   +9 more
europepmc   +1 more source

YC‐4‐3, a Novel Glycogen Synthase Kinase 3β Inhibitor, Alleviates the Endoplasmic Reticulum Stress of Macrophages in Primary Immune Thrombocytopenia

open access: yesAdvanced Science, Volume 12, Issue 17, May 8, 2025.
A patented GSK‐3β inhibitor (GSK‐3βi), new benzothiazepinone compounds (BTZs), YC‐4‐3, can modulate the inflammatory status of macrophages in primary immune thrombocytopenia (ITP), and improve the thrombocytopenia in murine ITP models by directly interacting with endoplasmic reticulum (ER) stress response.
Pengcheng Xu   +10 more
wiley   +1 more source

Prognostic values of regulatory T cells (Tregs) and Treg-related genes in gastric cancer

open access: yesCentral European Journal of Immunology, 2023
Liang Zheng   +8 more
doaj   +1 more source

A Spleen‐Targeted Tolerogenic mRNA‐LNPs Vaccine for the Treatment of Experimental Asthma

open access: yesAdvanced Science, Volume 12, Issue 13, April 3, 2025.
Splenic DCs‐targeted co‐delivery of nucleoside‐modified antigen mRNA and Cel‐loaded LNPs vaccine induces tolerogenic DCs and subsequent antigen‐specific CD4+ regulatory T cells for the treatment of experimental allergic asthma. Abstract Lipid nanoparticles (LNPs)‐based mRNA vaccines have witnessed their great advantages in the fight against infectious ...
Fazhan Wang   +15 more
wiley   +1 more source

Treg Depletion–enhanced IL-2 Treatment Facilitates Therapy of Established Tumors Using Systemically Delivered Oncolytic Virus [PDF]

open access: hybrid, 2008
Timothy Kottke   +12 more
openalex   +1 more source

Regulatory T cells in solid tumor immunotherapy: effect, mechanism and clinical application. [PDF]

open access: yesCell Death Dis
Pan Y   +7 more
europepmc   +1 more source

Novel immunotherapies for immune-mediated haemolytic anaemia in dogs and people [PDF]

open access: yes, 2015
Aerts   +111 more
core   +1 more source

Targeting USP1 Potentiates Radiation‐Induced Type I IFN‐Dependent Antitumor Immunity by Enhancing Oligo‐Ubiquitinated SAR1A‐Mediated STING Trafficking and Activation

open access: yesAdvanced Science, Volume 12, Issue 15, April 17, 2025.
Targeting USP1 is identified as a strategy that significantly enhances type I IFN‐dependent innate immune response within the TME following radiotherapy. Mechanistically, USP1 inhibition facilitates STING trafficking from ER to Golgi by preserving K27‐linked oligo‐ubiquitination of SAR1A, thereby facilitating efficient activation of the dsDNA‐cGAS ...
Weilin Zhou   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy